Published in Antimicrob Agents Chemother on May 08, 2017
Oral azole drugs as systemic antifungal therapy. N Engl J Med (1994) 3.96
The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. Drug Metab Dispos (2003) 2.32
Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis (2003) 2.08
Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun (2004) 1.99
In vitro and in vivo evidence for amphotericin B as a P-glycoprotein substrate on the blood-brain barrier. Antimicrob Agents Chemother (2014) 1.78
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
On the rate and extent of drug delivery to the brain. Pharm Res (2007) 1.53
Microdialysis. A novel tool for clinical studies of anti-infective agents. Eur J Clin Pharmacol (2001) 1.34
Tissue penetration of antifungal agents. Clin Microbiol Rev (2014) 1.13
Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts. Curr Opin Microbiol (2003) 1.10
[Guidelines in cryptococcosis--2008]. Rev Soc Bras Med Trop (2008) 0.99
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. J Antimicrob Chemother (2000) 0.95
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient. J Clin Pharm Ther (2010) 0.95
Voriconazole and fluconazole susceptibility of Candida isolates. J Med Microbiol (2002) 0.90
Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Mycopathologia (2004) 0.85
Free renal levels of voriconazole determined by microdialysis in healthy and Candida sp.-infected Wistar rats. Int J Antimicrob Agents (2008) 0.84
Validation of rapid and simple LC-MS/MS method for determination of voriconazole in rat plasma. J Pharm Biomed Anal (2007) 0.83
Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole. Clin Pharmacokinet (2016) 0.82
A retrospective analysis of patient-specific factors on voriconazole clearance. J Pharm Health Care Sci (2016) 0.81
Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis. Antimicrob Agents Chemother (2013) 0.81
Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats. Biomed Chromatogr (2015) 0.78
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP. Antimicrob Agents Chemother (2016) 0.78
Voriconazole: a novel treatment option for cryptococcal meningitis. Infect Dis (Lond) (2015) 0.78
Meningitis due to Cryptococcus neoformans: treatment with posaconazole. Curr HIV Res (2012) 0.78
Does the Anesthetic Urethane Influence the Pharmacokinetics of Antifungal Drugs? A Population Pharmacokinetic Investigation in Rats. J Pharm Sci (2015) 0.78
[Intraventricular cryptococcoma successfully treated with liposomal amphotericin B and voriconazole: a case report]. No Shinkei Geka (2012) 0.77
Opportunistic yeast pathogens: reservoirs, virulence mechanisms, and therapeutic strategies. Cell Mol Life Sci (2015) 0.77
Duloxetine enters the brain - But why is it not found in the cerebrospinal fluid. J Affect Disord (2015) 0.77
Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags. Braz J Infect Dis (2008) 0.77
An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole. Pharmacology (2010) 0.77
[Granulomatous form of cerebral cryptococcosis: a case report]. Arq Neuropsiquiatr (1995) 0.77
Pharmacokinetic Investigation of Quetiapine Transport across Blood-Brain Barrier Mediated by Lipid Core Nanocapsules Using Brain Microdialysis in Rats. Mol Pharm (2016) 0.77
[Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient]. Brain Nerve (2010) 0.76
Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis. Eur J Clin Pharmacol (2016) 0.76